SCHEMBL4853773

SCHEMBL4853773

COc1ccc(C=CC(=O)c2cc(-c3ccccc3C)ccc2OCCCN(C)C)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TNFRSF1A P19438 2/20 0.41
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
TUBB4A P04350 2/20 0.39
TUBB P07437 2/20 0.39
TUBA3C P0DPH7 2/20 0.39
TUBA1B P68363 2/20 0.39
TUBA4A P68366 2/20 0.39
TUBB4B P68371 2/20 0.39
TUBB3 Q13509 2/20 0.39
TUBB2A Q13885 2/20 0.39
TUBB8 Q3ZCM7 2/20 0.39
TUBA3E Q6PEY2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4846179 1.00 SLC6A9 (0.42) SLC6A9MAPTLMNAGAAATM
SCHEMBL4848486 0.96 SLC6A9 (0.45) SLC6A9MAPTLMNAGAAATM
SCHEMBL4852348 0.96 SLC6A9 (0.45) SLC6A9MAPTLMNAGAAATM
SCHEMBL4846183 0.91 LMNA (0.45) MAPTLMNAGAAATMSMN1; SMN2
SCHEMBL4851264 0.88 MAPT (0.45) SLC6A9MAPTLMNAGAAATM
SCHEMBL4848064 0.88 MAPT (0.45) SLC6A9MAPTLMNAGAAATM
SCHEMBL4854239 0.87 SLC6A9 (0.46) SLC6A9MAPTLMNAGAAATM
SCHEMBL4848047 0.87 SLC6A9 (0.46) SLC6A9MAPTLMNAGAAATM
SCHEMBL4848487 0.86 LMNA (0.46) SLC6A9MAPTLMNAGAAATM
SCHEMBL4856317 0.86 ABCG2 (0.46) SLC6A9MAPTLMNAGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed